Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion: WSJ

Canada

FILE PHOTO: Switzerland’s national flag flies in front of the logo of Swiss drugmaker Novartis in Basel, Switzerland, January 30, 2019. REUTERS/Arnd Wiegmann/File Photo

(Reuters) – Swiss drugmaker Novartis AG (NOVN.S) is nearing an agreement to acquire U.S. biotechnology firm The Medicines Co (MDCO.O) for about $7 billion, the Wall Street Journal reported on Saturday.

The deal, in which Novartis has agreed to pay $85 a share, could be announced this weekend, the Journal reported, citing people familiar with the matter.

Neither Novartis nor The Medicines Co were immediately available for comment on Saturday.

Reporting by Kanishka Singh in Bengaluru; editing by Jonathan Oatis

Products You May Like

Articles You May Like

Prepare to study in Canada
Study permit: Who can apply
Record-Setting Number Of Job Vacancies In Canada Leaves Employers Desperate For Workers
Canada Immigration Backlog Increases Amid Record Numbers Of New Permanent Residents
What Is A Canada Express Entry Profile?
Nova Scotia Gets IRCC Green Light To Bring In 41% More Immigrants
Canada Express Entry Draw: Ottawa Issues 636 PNP Invitations

Leave a Reply

Your email address will not be published.